Forex
AEG, Archer Aviation to build downtown L.A. vertiport for air taxis
Partners plan the first vertiport in downtown Los Angeles as part of a multi-year deal making Archer the exclusive air taxi operator at L.A. LIVE, ahead of the 2028 Olympics.
Clearmind secures U.S. patent publication for MDMA-PEA PTSD therapy
Patent covers combination therapy targeting PTSD, anxiety and eating disorders. Clearmind and NeuroThera Labs have filed 13 global patent applications from their collaboration.
U.S. launches campaign to isolate Iran from global economy
Treasury Secretary Scott Bessent outlines plan to sever Iran’s financial ties worldwide, targeting digital assets, gold and aviation. Deadlines set for countries to end cooperation or face sanctions.
Zelenskiy says Ukraine negotiating with Russia over Black Sea attacks
President Volodymyr Zelenskiy signals diplomatic talks with Moscow as shipping through Greater Odessa remains constrained. Ukraine also plans to bolster air defenses in the region.
Raymond James downgrades airlines on higher fuel costs, upgrades Allegiant
Analyst cuts estimates across the sector as jet fuel prices surge 39% quarter-to-date, while lifting Allegiant Travel to Strong Buy on margin recovery and scale gains.
H.C. Wainwright maintains $12 buy rating on AC Immune after stock surge
Analyst reiterates bullish stance on biotech firm following 14.6% weekly gain and positive Phase 1 data for Alzheimer’s drug ACI-19764. Target implies nearly 314% upside from current levels.
Zelenskiy vows no surrender as Ukraine marks 35th independence anniversary
President Zelenskiy reaffirmed Ukraine's commitment to peace but ruled out territorial concessions during Independence Day ceremonies. British PM Burnham pledged support for long-range missile production amid ongoing frontline clashes.
Quest to roll out FDA-cleared Roche Alzheimer’s blood test by Q4 2026
Quest Diagnostics plans to launch Roche’s Elecsys pTau217 blood test in its AD-Detect portfolio by late 2026, expanding access to Alzheimer’s pathology screening. The FDA-cleared test offers a 10% indeterminate rate and aligns with clinical guidelines.
U.S. threatens Canada with 50% tariffs on autos, trucks, steel from 2027
Trump escalates trade dispute by proposing steep tariffs on key Canadian imports, while Ottawa announces retaliatory measures. Zoll measures take effect immediately on select goods.
Roche gains FDA approval for Alzheimer's blood test
Swiss drugmaker secures first U.S. clearance for a single-biomarker blood test detecting Alzheimer's-linked amyloid pathology, aiming to simplify early diagnosis.
Vanda gains EU orphan status for psoriasis drug imsidolimab
European Commission grants designation for imsidolimab, a first for Generalized Pustular Psoriasis in the EU. Vanda eyes December FDA decision as exclusivity benefits loom.
Japan approves Insmed’s brensocatib for non-cystic fibrosis bronchiectasis
The Ministry of Health, Labour and Welfare of Japan has cleared BRINSUPRI (brensocatib) for adults and adolescents aged 12 and older, making it the first approved therapy for the condition in the country.
Vanda gains EU orphan drug status for imsidolimab to treat GPP
EU designation follows prior U.S. and Japanese approvals for the IL-36 receptor inhibitor, positioning imsidolimab for potential late-2030s exclusivity in Europe.
Moody’s upgrades Pakistan’s sovereign rating to B3 from Caa1
Upgrade reflects improving external position and fiscal metrics amid sustained FX reserve growth and monetary easing. Outlook remains stable.
China’s 800 bln yuan policy financing tool opens for project bids
Infrastructure funding vehicle faces delays as local authorities struggle to submit viable projects despite Beijing’s push to accelerate disbursements.
EU approves Gilead’s Trodelvy-Keytruda combo for metastatic TNBC
Combination therapy targets PD-L1-positive triple-negative breast cancer patients ineligible for prior systemic treatment. Phase 3 data showed 35% reduction in disease progression or death vs. standard therapy.
China urges Middle East de-escalation as U.S.-Iran tensions rise
Beijing calls for immediate dialogue as regional tensions hit a critical point, while Washington threatens new economic measures against Iran's trade partners.
EU approves Gilead, Merck combo for metastatic triple-negative breast cancer
European Commission authorizes Trodelvy-Keytruda regimen for PD-L1-positive TNBC patients ineligible for prior systemic therapy. Combination cut disease progression risk by 35% in Phase 3 trial.
Parsons recebe opção de contrato de defesa antimíssil no valor de US$ 514 milhões
A Parsons obteve a opção de um contrato de defesa antimíssil avaliado em US$ 514 milhões.
EUR/USD hits 1.1700, highest since May, as dollar weakens
Euro gains ground on improving eurozone data and US Treasury bond buyback expansion, while technical levels suggest limited upside ahead of key US economic releases this week.
Dollar slips as U.S. policy risks weigh ahead of key data and speeches
U.S. currency weakens near recent lows as investors weigh fiscal and trade policy developments, including new Iran sanctions and Treasury auctions. EUR/USD seen consolidating above 1.1660 support.
Dollar’s fate tied to U.S. long bond as Iran sanctions, Fed weigh on greenback
The greenback’s traditional safe-haven bid is clouded by rising fiscal risks and potential oil supply shocks, with traders eyeing the 30-year Treasury yield as the decisive driver this week.
Analyst flags potential for 250-pip move in GBP/USD trade
A technical analysis suggests GBP/USD could extend gains toward a key resistance level, with a potential 250-pip profit if the scenario unfolds. The outlook hinges on support holding at a specified level.
CB&I wins $50-100M operations contract in Côte d’Ivoire
Finance Review Daily is tracking this developing story; finance review daily will provide updates as verified details become available.